• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches  
Title Created Date
Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography 19 August 2013
The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell lines 14 August 2013
The validity of melatonin as an oncostatic agent 13 August 2013
Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160 22 July 2013
Inhibition of tumor cell kinetics and serum insulin growth factor I levels by octreotide in colorectal cancer patients 22 July 2013
Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta 16 July 2013
Somatostatin receptors and breast cancer 15 July 2013
Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes 15 July 2013
13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma 07 July 2013
Growth-hormone and prolactin excess 06 July 2013
Display # 

Page 57 of 60

  • Start
  • Prev
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • Next
  • End

Search

Follow us...

Latest

  • Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin
  • Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors
  • Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination
  • Melatonin attenuates bone cancer pain via the SIRT1/HMGB1 pathway
  • Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
  • Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients
  • A Review of Biological and Pharmacological Actions of Melatonin: Oxidant and Prooxidant Properties
  • Melatonin as Antioxidant Under Pathological Processes
  • Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage
  • Melatonin as antioxidant, geroprotector and anticarcinogen
  • The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor
  • Does the use of melatonin overcome drug resistance in cancer chemotherapy?
  • Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
  • Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
  • Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
  • Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms
  • Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management
  • Nocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer